Technology (UPN: 164)

Technology Antiviral vaporizing balm for colds, flu and other contagious diseases propagated via air or breath.
Organisation Type Research Organization (Public or Private)
Organisation Region North America
Overview A combined formula of natural oils that the vapors of which kill a number of airborne pathogens. Used as a prophylactic in high risk zones or as a remedy for sinus or lung infections.
Description

Mixing two matural plant based oils in a petroleum jelly balm allows the vapors to pre-treat breathing air to kill a number of contageous pathogens. From rhinovirus to tuberculosis, from MRSA to fecal bacteria, from candida albicans to tinea versacolor, this breakthrough formulation has a broad range of pathogens that it will destroy all while being human and pet friendly. It penetrates tissue significantly, and when used topically can destroy underdermal colonies of fungus in 4-6 applications. It utilizes two mechanisms of action each complimenting the other. The one-two action broadens the species of pathogen, it will irradicate and makes the pathogen succumb more quickly. 

Possible Applications:

Prophylactic airborne contagion prevention, Prophylactic airborne infection prevention, Cure for Cold, some flu, airborne and dermatology diseases, Cure for colds, flu, airborne diseases, skin diseases.

Competitive Advantage

Food-based ingredients (safe from a regulatory standpoint), synthesizable or from plants, does not have to contact patient, effective and powerful.

Development Stage:

In user / Testing result available

Proof-of-concept or Laboratory prototype

Research or Experimental

Working prototype or Sample ready for testing

Intellectual Property:

Patent (PCT) Pending

Innovator An Incubator company that manages and develops intellectual property.
slider